A total of 74 Private Equity/Venture Financing deals (pending and completed) were announced in the Healthcare of Switzerland, in the last twelve months resulting in a total deal value of over $1,739.2 million. In the LTM period, December 2021 turned out to be the most prolific in terms of deal size, with a total deal value of $615.5 million, resulting in an average deal value of $68.4 million during that month. On the other hand, the month of December 2021 was the most prolific in terms of deal volume, recording a total of 9 deals, resulting in an average deal value of $68.4 million during that month.
Of the 74 deals, the deal secured between PPF Group NV and SOTIO Biotech AG, was the largest Private Equity/Venture Financing deal in the Switzerland Healthcare sector, which was valued at $317.1 million and was completed on December 2, 2021. The second-largest deal was between GEM Global Yield LLC SCS and Quercis Pharma AG, while the third-largest deal was between AlbaCore Capital LLP and MindMaze SA. The GEM Global Yield LLC SCS-Quercis Pharma AG deal and the AlbaCore Capital LLP-MindMaze SA deal were valued at $150.0 million and $125.0 million, respectively. The fourth-largest deal was between Cowen Healthcare Investments; Forbion Capital Partners Management Services BV; Novartis Venture Fund; Pfizer Venture Investments; Pontifax Ltd; Syncona Ltd-Anaveon AG valued at $118.9 million, whereas the deal between AlbaCore Capital LLP; Concord Health Partners LLC; Hambro Perks Ltd-MindMaze SA valued at $105.0 million was the fifth-largest deal.
Cumulatively, the top five deals amounted to $816.0 million and accounted for nearly 46.92% of the total deals (by value) announced during the last twelve months.
United States of America
China
Switzerland
United States of America
United States of America
United States of America
United States of America
United States of America
United States of America
Japan
Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.
Access more premium companies when you subscribe to Explorer
Contact the team or request a demo to find out how our data can drive your business forward